Browse Category

Earnings Reports 2 December 2025 - 3 December 2025

POET Technologies (NASDAQ: POET) Stock on December 3, 2025: Cash-Rich AI Optics Play Faces Sharp Volatility After Q3 Earnings

POET Technologies (NASDAQ: POET) Stock on December 3, 2025: Cash-Rich AI Optics Play Faces Sharp Volatility After Q3 Earnings

As of the U.S. midday session on December 3, 2025, POET Technologies Inc. is trading around $4.68 per share, up roughly 1–2% on the day from a previous close near $4.61. That price values the photonics and AI-connectivity specialist at about $600 million in market capitalization, depending on the data provider. Stock Titan+1
Marvell Technology (MRVL) Soars on Celestial AI Deal and Record Q3 Earnings: What Investors Need to Know Now

Marvell Technology (MRVL) Soars on Celestial AI Deal and Record Q3 Earnings: What Investors Need to Know Now

Marvell Technology, Inc. has jumped back into the AI spotlight after reporting record fiscal Q3 2026 results and announcing a multibillion‑dollar acquisition of optical‑interconnect startup Celestial AI. Together, the earnings beat and the deal are reshaping Wall Street’s view of the mid‑cap chipmaker as a core enabler of AI data centers rather than just another networking name. TipRanks+3Marvell Technology, Inc.+3Marvell Technology, Inc.+3
Paragon Banking Group (PAG.L) Shares Drop After FY 2025 Results: Dividend Hike, £50m Buyback and 2026 Margin Squeeze Explained

Paragon Banking Group (PAG.L) Shares Drop After FY 2025 Results: Dividend Hike, £50m Buyback and 2026 Margin Squeeze Explained

Paragon Banking Group PLC shares fell sharply on 3 December 2025 despite the specialist lender reporting another year of robust profits, rising dividends and a fresh share buyback programme. The market reaction focused less on the 2025 numbers and more on guidance for a squeeze in net interest margins in 2026 and higher provisions linked to UK motor finance redress.
Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

As of early December 3, 2025, Elevance Health, Inc. is trading around $331 per share, leaving the managed-care giant roughly 30% below its 52‑week high near $459, even after a strong third‑quarter earnings beat and renewed institutional buying.Investing.com+1 Over the past 12 months the stock is down about 18%, significantly lagging the S&P 500.PortfoliosLab
3 December 2025
3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

After years of legal headaches and sluggish growth, the industrial conglomerate now sits near a four‑year high, closing at $171.56 on 2 December 2025, just shy of its 52‑week peak around $172.85. That price gives 3M a market capitalization of about $91 billion, a trailing P/E of 27.4 and a forward P/E near 20.3, with a dividend yield around 1.7% on an annual payout of $2.92 per share. StockAnalysis
Salesforce (CRM) Stock: Price Today, AI Strategy and 2030 Forecast Ahead of Q3 Earnings — December 2, 2025

Salesforce (CRM) Stock: Price Today, AI Strategy and 2030 Forecast Ahead of Q3 Earnings — December 2, 2025

Salesforce, Inc. heads into a pivotal earnings week with its share price hovering in the mid‑$230s and Wall Street laser‑focused on whether the company’s big bet on AI and “agentic” workflows can re‑ignite growth. As of the close on December 2, 2025, Salesforce stock traded around $234.71, up roughly 0.8% on the day, with after‑hours quotes inching closer to $235.69. StockAnalysis
CrowdStrike (CRWD) Tops Q3 2026 Earnings, Lifts Outlook on AI Demand as Valuation Debate Intensifies

CrowdStrike (CRWD) Tops Q3 2026 Earnings, Lifts Outlook on AI Demand as Valuation Debate Intensifies

CrowdStrike’s latest earnings report has turned December 2, 2025 into a pivotal day for one of the market’s flagship AI‑cybersecurity stocks. After the closing bell, the company reported fiscal third‑quarter 2026 results that edged past Wall Street expectations, raised its full‑year outlook, and showcased record demand for its Falcon platform — all while investors and analysts wrestle with whether the stock’s rich valuation leaves more upside or looming downside.
1 229 230 231 232 233 270
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 94 / 100
#2 STRONG BUY

AerCap

NYSE: AER 92 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 BUY

Chevron

NYSE: CVX 86 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.